Pharmaceuticals News

Aug 28, 2014 FDA Approves Conversion of SolirisĀ® (eculizumab) Accelerated Approval in aHUS to Regular Approval for the Treatment of Patients with aHUS

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Pellentesque auctor aliquam lectus eget venenatis. Nam fermentum est quam, sit amet porttitor quam blandit nec.

Morbi condimentum felis felis, in auctor sapien commodo ac. Donec ege

More News
For General
Enquiries Call Us on + 44 (0) 1189 653845